GoodRx Target of Unusually High Options Trading (NASDAQ:GDRX)

Key Points

• GoodRx Holdings, Inc. experienced a significant spike in options trading, with 10,790 call options purchased, indicating a 431% increase from the average volume.
• A major shareholder, Equity Vii L.P. Spectrum, sold 16,016 shares for a total of approximately $64,864.80 at an average price of $4.05.
• GoodRx's stock has fluctuated between a 1-year low of $3.31 and a high of $7.20, with a recent price of $4.60 after a drop of $0.44.

GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) saw unusually large options trading on Thursday. Stock investors purchased 10,790 call options on the company. This represents an increase of approximately 431% compared to the typical volume of 2,032 call options.

Insider Activity

In other news, major shareholder Equity Vii L.P. Spectrum sold 16,016 shares of the business's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $4.05, for a total transaction of $64,864.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 4.53% of the stock is currently owned by corporate insiders.

Institutional Trading of GoodRx

A number of institutional investors have recently added to or reduced their stakes in GDRX. Deutsche Bank AG acquired a new position in shares of GoodRx in the fourth quarter valued at approximately $137,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in GoodRx by 70.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 149,945 shares of the company's stock valued at $697,000 after acquiring an additional 61,924 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of GoodRx by 12.2% during the first quarter. Assenagon Asset Management S.A. now owns 362,713 shares of the company's stock worth $1,600,000 after purchasing an additional 39,337 shares during the period. CWA Asset Management Group LLC acquired a new stake in shares of GoodRx during the first quarter worth $292,000. Finally, Teacher Retirement System of Texas acquired a new stake in shares of GoodRx in the 1st quarter worth about $218,000. Hedge funds and other institutional investors own 63.77% of the company's stock.

GoodRx Price Performance

Shares of GDRX stock traded down $0.44 on Thursday, reaching $4.60. 6,351,214 shares of the company were exchanged, compared to its average volume of 2,186,823. GoodRx has a 1 year low of $3.31 and a 1 year high of $7.20. The company has a market cap of $1.60 billion, a price-to-earnings ratio of 45.95, a P/E/G ratio of 1.84 and a beta of 1.23. The company has a debt-to-equity ratio of 0.75, a quick ratio of 4.21 and a current ratio of 4.21. The business has a 50-day moving average price of $4.27 and a 200 day moving average price of $4.39.

GoodRx (NASDAQ:GDRX - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.01). GoodRx had a net margin of 4.33% and a return on equity of 8.86%. The firm had revenue of $203.07 million during the quarter, compared to analysts' expectations of $205.72 million. During the same period last year, the company earned $0.08 EPS. The business's quarterly revenue was up 1.2% on a year-over-year basis. Equities research analysts forecast that GoodRx will post 0.13 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on GDRX shares. Raymond James Financial downgraded shares of GoodRx from a "strong-buy" rating to an "outperform" rating in a research report on Friday, August 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $6.00 price target on shares of GoodRx in a research report on Monday, August 11th. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $5.80.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.